Hyderabad, April 21 Leading vaccine maker Bharat Biotech and the Indian Council of Medical Research (ICMR) on Wednesday announced interim results from phase 3 clinical trials of Covaxin, which show 78 per cent overall clinical efficacy and 100 per cent
New Delhi, Jan 15 The Delhi government has rationed the tranche of two Covid-19 vaccines it has stocked in 81 hospitals finalised for the launch of a massive immunization drive against the novel coronavirus in the national capital. However, the
New Delhi, Jan 4 Hyderabad-based Bharat Biotech said on Monday that its vaccine is efficient against the mutant strain of novel coronavirus found in the UK while announcing that its data would be made public within a week. CMD Dr
New Delhi, Jan 4 Hyderabad-based Bharat Biotech has sent the first batch of its Covid vaccine, Covaxin, to the government for further distribution in the immunisation drive the country is set to start in coming days, its CMD Dr Krishna
New Delhi, Jan 2 A committee of experts assessing the coronavirus vaccines has called Hyderabad-based Bharat Biotech for a meeting at 1.30 pm on Saturday, a day after the firm was asked to present more data on its ‘Covaxin’ to
Hyderabad, Dec 30 Bharat Biotech said on Tuesday that its vaccine candidate, Covaxin, will be effective in dealing with new strains of coronavirus. Bharat Biotech Chairman and Managing Director Krishna Ella said the protein components of inactive Covaxin will take
New Delhi, Dec 8 (IANS) Covaxin, the COVID vaccine candidate by Hyderabad-based vaccine manufacturer Bharat Biotech Limited, being developed in collaboration with the Indian Council of Medical Research (ICMR), is likely to be available for use of the general public by
New Delhi, Dec 9 Covaxin, the COVID vaccine candidate by Hyderabad-based vaccine manufacturer Bharat Biotech Limited, being developed in collaboration with the Indian Council of Medical Research (ICMR), is likely to be available for use of the general public by
Bengaluru, Dec 2 The Phase-III clinical trial of Covid-19 vaccine (Covaxin) being developed by Bharat Biotech would begin at the privately-run Vydehi multi-specialty hospital here from Wednesday, an official said on Tuesday. “The ICMR (Indian Council of Medical Research) has
New Delhi, Sep 9 Covid-19 is raging like a wild fire across the country, making India the second worst hit country after the US. But there is a bright spot amid this mayhem — India’s first indigenous Covid-19 vaccine, Covaxin
Guwahati, Aug 19 The Gauhati Medical College and Hospital (GMCH) has been selected for the second phase clinical testing of India’s indigenously developed coronavirus vaccine, COVAXIN, Assam Health Minister Himanta Biswa Sarma said on Tuesday. He said the GMCH would
Bhubaneswar, July 28 The human clinical trial of India’s first possible anti-Covid vaccine ‘Covaxin’ began at an institute here on Monday, an official said. The human trial of the coronavirus vaccine has begun at the Institute of Medical Sciences and
 |
 |
 |
|---|---|---|
 |
 |
 |
 |
 |
 |
